4oyq

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 3: Line 3:
== Structural highlights ==
== Structural highlights ==
<table><tr><td colspan='2'>[[4oyq]] is a 3 chain structure with sequence from [http://en.wikipedia.org/wiki/Human Human]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4OYQ OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4OYQ FirstGlance]. <br>
<table><tr><td colspan='2'>[[4oyq]] is a 3 chain structure with sequence from [http://en.wikipedia.org/wiki/Human Human]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4OYQ OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4OYQ FirstGlance]. <br>
-
</td></tr><tr><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=1X2:6-ISOTHIOCYANATOHEXYLBENZENE'>1X2</scene>, <scene name='pdbligand=GOL:GLYCEROL'>GOL</scene>, <scene name='pdbligand=SO4:SULFATE+ION'>SO4</scene><br>
+
</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=1X2:6-ISOTHIOCYANATOHEXYLBENZENE'>1X2</scene>, <scene name='pdbligand=GOL:GLYCEROL'>GOL</scene>, <scene name='pdbligand=SO4:SULFATE+ION'>SO4</scene></td></tr>
-
<tr><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[3wns|3wns]], [[3wnr|3wnr]], [[3wnt|3wnt]], [[4osf|4osf]]</td></tr>
+
<tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[3wns|3wns]], [[3wnr|3wnr]], [[3wnt|3wnt]], [[4osf|4osf]]</td></tr>
-
<tr><td class="sblockLbl"><b>[[Gene|Gene:]]</b></td><td class="sblockDat">MIF, GLIF, MMIF ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=9606 HUMAN])</td></tr>
+
<tr id='gene'><td class="sblockLbl"><b>[[Gene|Gene:]]</b></td><td class="sblockDat">MIF, GLIF, MMIF ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=9606 HUMAN])</td></tr>
-
<tr><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4oyq FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4oyq OCA], [http://www.rcsb.org/pdb/explore.do?structureId=4oyq RCSB], [http://www.ebi.ac.uk/pdbsum/4oyq PDBsum]</span></td></tr>
+
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4oyq FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4oyq OCA], [http://www.rcsb.org/pdb/explore.do?structureId=4oyq RCSB], [http://www.ebi.ac.uk/pdbsum/4oyq PDBsum]</span></td></tr>
-
<table>
+
</table>
== Disease ==
== Disease ==
[[http://www.uniprot.org/uniprot/MIF_HUMAN MIF_HUMAN]] Genetic variations in MIF are associated with susceptibility to rheumatoid arthritis systemic juvenile (RASJ) [MIM:[http://omim.org/entry/604302 604302]]. An inflammatory articular disorder with systemic-onset beginning before the age of 16. It represents a subgroup of juvenile arthritis associated with severe extraarticular features and occasionally fatal complications. During active phases of the disorder, patients display a typical daily spiking fever, an evanescent macular rash, lymphadenopathy, hepatosplenomegaly, serositis, myalgia and arthritis.
[[http://www.uniprot.org/uniprot/MIF_HUMAN MIF_HUMAN]] Genetic variations in MIF are associated with susceptibility to rheumatoid arthritis systemic juvenile (RASJ) [MIM:[http://omim.org/entry/604302 604302]]. An inflammatory articular disorder with systemic-onset beginning before the age of 16. It represents a subgroup of juvenile arthritis associated with severe extraarticular features and occasionally fatal complications. During active phases of the disorder, patients display a typical daily spiking fever, an evanescent macular rash, lymphadenopathy, hepatosplenomegaly, serositis, myalgia and arthritis.
Line 17: Line 17:
</StructureSection>
</StructureSection>
[[Category: Human]]
[[Category: Human]]
-
[[Category: Dale, E J.]]
+
[[Category: Dale, E J]]
-
[[Category: Gamble, A B.]]
+
[[Category: Gamble, A B]]
-
[[Category: Gommans, A L.]]
+
[[Category: Gommans, A L]]
-
[[Category: Hampton, M B.]]
+
[[Category: Hampton, M B]]
-
[[Category: Nakatani, Y.]]
+
[[Category: Nakatani, Y]]
-
[[Category: Rutledge, M T.]]
+
[[Category: Rutledge, M T]]
-
[[Category: Smith, R A.J.]]
+
[[Category: Smith, R A.J]]
-
[[Category: Spencer, E S.]]
+
[[Category: Spencer, E S]]
-
[[Category: Tyndall, J D.A.]]
+
[[Category: Tyndall, J D.A]]
-
[[Category: Vo, C T.]]
+
[[Category: Vo, C T]]
-
[[Category: Wilbanks, S M.]]
+
[[Category: Wilbanks, S M]]
[[Category: Cytokine]]
[[Category: Cytokine]]
[[Category: Isomerase]]
[[Category: Isomerase]]
[[Category: Isomerase-isomerase inhibitor complex]]
[[Category: Isomerase-isomerase inhibitor complex]]
[[Category: Tautomerase]]
[[Category: Tautomerase]]

Revision as of 14:57, 5 January 2015

(6-isothiocyanatohexyl)benzene inhibitor complexed with Macrophage Migration Inhibitory Factor

4oyq, resolution 1.70Å

Drag the structure with the mouse to rotate

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools